Cancer Research UK Cambridge Institute

The Cancer Research UK Cambridge Institute aims to bring the scientific strengths of Cambridge to bear on practical questions of cancer diagnosis, treatment and prevention. The Institute focuses specifically on the practical application of high-quality basic research.

About us

Latest news

  • News

    Azeria Therapeutics announces £32 million Series B financing

    Azeria Therapeutics (Azeria), a newly formed pioneer factor drug discovery company founded by Group Leader Prof Jason Carroll, today announced a £32 million Series B financing.  Azeria was originally founded in 2017 by Sixth Element Capital, manager of the CRT Pioneer Fund and Cancer Research UK’s Commercial Partnerships team with the aim of building a […]

    Find out more
  • News

    Blocking a survival mechanism could tackle melanoma treatment resistance

    The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications today. Researchers funded by an AstraZeneca and Cancer Research UK Cambridge Centre partnership has demonstrated an approach, used in […]

    Find out more
  • News

    Cambridge scientists lead the way in next generation radiotherapy research

    Researchers from across Cambridge are set to receive £8 million over the next five years to pioneer new radiotherapy technologies and techniques that could help more people survive cancer in the future. Cambridge has been chosen to be one of just seven centres of excellence in a UK-wide network that will accelerate advances in radiotherapy research. […]

    Find out more
  • News

    Accumulation of DNA mutations found in healthy liver leads to disease

    New insights into the journey from health to disease in the human liver have been made by scientists at the Wellcome Sanger Institute, Cancer Research UK Cambridge Institute, the University of Cambridge and their collaborators. In the largest study of its kind, the team documented in unprecedented detail how the accumulation of changes in our […]

    Find out more

Who we work with